Kayıkçıoğlu, Erkan, and Arif Hakan Onder. “The Pan-Immune-Inflammation-Value Predicts the Survival of Patients With Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated With CDK4/6 Inhibitors”. Chronicles of Precision Medical Researchers 3, no. 3 (October 15, 2022). Accessed February 3, 2023. https://chronpmr.com/index.php/cpmr/article/view/145-149.